YIV-906 Potentiated anti-PD1 Action Against Hepatocellular Carcinoma by Enhancing Adaptive and Innate Immunity in the Tumor Microenvironment.
Xiaochen Yang(China Academy of Chinese Medical Sciences), Yung‐Chi Cheng(Yale University)
Cited by 4
Related Papers
Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment
|BMC Medical Genomics|2011|71
YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment
|Scientific Reports|2021|32
DCB-3503, a Tylophorine Analog, Inhibits Protein Synthesis through a Novel Mechanism
|PLoS ONE|2010|23
Receptor FGFRL1 does not promote cell proliferation but induces cell adhesion
|International Journal of Molecular Medicine|2016|18